Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.

Wiviott, Stephen D

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. [electronic resource] - Circulation Oct 2008 - 1626-36 p. digital

Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1524-4539

10.1161/CIRCULATIONAHA.108.791061 doi


Administration, Oral
Aged
Clopidogrel
Coronary Thrombosis--complications
Diabetes Mellitus, Type 1--complications
Diabetes Mellitus, Type 2--complications
Female
Humans
Hypoglycemic Agents--administration & dosage
Insulin--administration & dosage
Kaplan-Meier Estimate
Male
Middle Aged
Myocardial Infarction--complications
Myocardial Ischemia--complications
Piperazines--administration & dosage
Platelet Aggregation Inhibitors--administration & dosage
Prasugrel Hydrochloride
Thiophenes--administration & dosage
Thrombolytic Therapy--methods
Ticlopidine--administration & dosage
Treatment Outcome